Willingdon Wealth Management’s Guardant Health GH Stock Holding History

Willingdon Wealth Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3	Closed	–	–	438
2019 Q3	$0	Buy	+3	New	+$264	﹤0.01%	517

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Willingdon Wealth Management's GH Position: Q4 2019 in Review

Willingdon Wealth Management sold out of Guardant Health (GH) in Q4 2019, closing a stake of 3 shares.

Willingdon Wealth Management first reported a position in GH in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 268 funds tracked by Wall St. Rank hold GH as of Q4 2019.

Willingdon Wealth Management reported no remaining Guardant Health position as of Q4 2019 after selling out during the quarter.
Willingdon Wealth Management sold 3 Guardant Health shares in Q4 2019.
Willingdon Wealth Management first reported a position in Guardant Health in Q3 2019 and held it in 1 quarter.
Willingdon Wealth Management's Guardant Health position peaked at $0 in Q3 2019.
268 funds tracked by Wall St. Rank held Guardant Health as of Q4 2019.

Based on Willingdon Wealth Management's 13F filing for Q4 2019, filed 10 Feb 2020.